Abstract
Photochemical ligand release from metal complexes may be exploited in the development of novel photoactivated chemotherapy agents for the treatment of cancer and other diseases. Highly intriguing photochemical behavior is reported for two ruthenium(II) complexes bearing conformationally flexible 1,2,3-triazole-based ligands incorporating a methylene spacer to form 6-membered chelate rings. [Ru(bpy)(2)(pictz)](2+) (1) and [Ru(bpy)(2)(btzm)](2+) (2) (bpy = 2,2 '-bipyridyl; pictz = 1-(picolyl)-4-phenyl-1,2,3-triazole; btzm = bis(4-phenyl-1,2,3-triazol-4-yl)methane) exhibit coordination by the triazole ring through the less basic N2 atom as a consequence of chelation and readily undergo photochemical release of the pictz and btzm ligands (phi = 0.079 and 0.091, respectively) in acetonitrile solution to form cis-[Ru(bpy)(2)(NCMe)(2)](2+) (3) in both cases. Ligand-loss intermediates of the form [Ru(bpy)(2)(kappa(1)-pictz or kappa(1)-btzm)(NCCD3)](2+) are detected by H-1 NMR spectroscopy and mass spectrometry. Photolysis of 1 yields three ligand-loss intermediates with monodentate pictz ligands, two of which form through simple decoordination of either the pyridine or triazole donor with subsequent solvent coordination (4-tz((N2)) and 4-py, respectively). The third intermediate, shown to be able to form photochemically directly from 1, arises through linkage isomerism in which the monodentate pictz ligand is coordinated by the triazole N3 atom (4-tz((N3))) with a comparable ligand-loss intermediate with an N3-bound kappa(1)-btzm ligand also observed for 2.